Data Giant Equinix Buys Telecity
U.S. data center operator giant Equinix won a scramble to
acquire U.K.-based peer Telecity Group in a cash and share offer
worth $3.60 billion.
Crisis-Stricken FIFA Gears Up for Election
Hundreds of FIFA officials gathered in Zurich to elect a leader,
with divisive President Joseph "Sepp" Blatter expected to secure a
fifth straight term.
Apple Buys German Augmented-Reality Firm Metaio
Apple acquired Metaio, a German maker of augmented-reality
technology that can turn any surface into a touch screen.
NTSB Blames Shell for Alaska Ship Accident
Federal investigators have blamed Royal Dutch Shell Plc and its
contractors for the December 2012 shipwreck of a drill ship off the
coast of Alaska.
China to Ease Limits on Overseas Investments
Beijing is set to announce changes that will allow individuals
and businesses to directly purchase stocks, bonds and real estate
in foreign markets-part of a long-stated goal of making the yuan a
global currency.
China's Ctrip Outage Due to Staff Error, Not Hack
Ctrip.com International on Friday blamed staff error rather than
a hack for an outage on Thursday.
Daum Kakao to Buy Path's Social Media Services
The purchase marks Daum Kakao's boldest move to expand beyond a
home market where it dominates.
Moody's Upgrades Four Top U.S. Banks
Moody's Investors Service said that it was upgrading the ratings
of four of the largest U.S. banks after the company determined that
some creditors would suffer fewer losses if those banks were to
fail.
Judge Presses Both Sides in Battle Over Sysco Merger
A federal judge heard lively closing arguments Thursday in the
FTC's challenge to the planned merger of rival food distributors
Sysco and US Foods, pressing both sides on potential weaknesses in
their positions.
Amazon to Add Its Own Line of Food
Amazon.com is preparing to broadly expand its fledgling lineup
of private-label brands to include grocery items such as milk,
cereal, and baby food, as well as household cleaners.
Merck Files New Drug Application for Hepatitis Combination
Merck & Co. has submitted a New Drug Application to the U.S.
Food and Drug Administration for an experimental drug combination
for treating certain chronic hepatitis C patients.